Raymond James Financial »

Compass Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $430k 80k 5.37
2025-06-30 $13k 4.9k 2.60

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)

View all positions for Raymond James Financial

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics